
Astatine is a rare and radioactive element with the symbol At and atomic number 85. It occurs in nature in extremely small quantities and has short-lived radioactive properties. It is difficult to observe and can only be studied in laboratory conditions. History Astatine was first synthesized in 1940 by American chemists. Its name derives from the Greek word “astatos,” meaning “not stable,” due to its high radioactivity and rapid decay. Physical Properties Astatine has a metallic appearance, but
EN
İbrahim Filiz

Smart drugs are biotechnological medications that are considered a revolutionary advancement in cancer treatment, directly targeting cancer cells while avoiding damage to healthy cells. These drugs aim to neutralize cancer cells by analyzing their genetic and molecular characteristics. Unlike conventional chemotherapy, they have fewer side effects and enable personalized treatment. History and Development The first targeted cancer therapies were developed in the early 2000s. Thanks to advances i
ENFatma Demirtaş

Prof. Dr. Aziz Sancar (born 8 September 1946, Savur, Mardin) is a Turkish scientist biochemist molecular biologist and academic. He is among the leading figures in modern molecular biology due to his pioneering research in DNA repair cell cycle biological clocks and cancer therapy. In 2015 he was awarded the Nobel Prize in Chemistry jointly with Paul Modrich and Tomas Lindahl for their mechanistic studies of DNA repair. Sancar continues his research as a faculty member in the Department of Bioch
EN
Yusuf Bilal Akkaya

Smart drugs are biotechnological medications designed to directly target cancer cells while sparing healthy cells, representing a breakthrough in cancer treatment revolution. These drugs aim to neutralize cancer cells by analyzing their characteristics at the cellular and molecular levels. Unlike conventional chemotherapy, they exhibit fewer side effects and enable personalized treatment opportunity. History and Development The first targeted cancer therapies were developed in the early 2000s. A
ENFatma Demirtaş